Investor Relations
Honesty and integrity, innovation and truth-seeking, quality first, teamwork, sustainable operations
Corporate Governance
- Shareholders’ Meeting and Annual Report
- Year 2023
Regular Shareholders’ Meeting 2023.06.27
- Year 2022
Regular Shareholders’ Meeting 2022.06.30
- Year 2021
Regular Shareholders’ Meeting 2021.06.30
1st Extraordinary General Meeting 2021.12.14
- Year 2020
Regular Shareholders’ Meeting 2020.06.30
1st Extraordinary General Meeting 2020.11.30
- Year 2019
Regular Shareholders’ Meeting 2019.06.27
- Year 2018
Regular Shareholders’ Meeting 2018.06.27
1st Extraordinary General Meeting 2018.10.03
- Past Financial Statements
- Important Articles of Incorporation and Measures
Articles of Incorporation
Procedures for the Election of Directors
Board of Directors Meeting Regulations
Organizational Charter of the Audit Committee
Organizational Charter of the Compensation Committee
Rules Shareholders’ Meetings
Procedures for Acquiring or Disposing of Assets
Operating Procedures for Endorsements and Guarantees
Operating Procedures for Lending Funds to Other Parties
Rules for performance Evaluation of Board of Directors
- Prospectus
UBI Pharma Inc.
No.45, Guangfu N. Rd., Hukou Township, Hsinchu County 303036, Taiwan (R.O.C.)
- Tel：+886-3-5977676
- Fax：+886-3-5981173